Literature DB >> 28674372

Deep Cutaneous Ulcers in Dermatomyositis.

Takao Nagashima1, Jun Nakamura1, Masahiro Iwamoto1, Seiji Minota1.   

Abstract

Entities:  

Keywords:  Gottron's sign; anti-melanoma differentiation-associated gene 5 antibody; cutaneous ulcer; dermatomyositis

Year:  2017        PMID: 28674372      PMCID: PMC5519485          DOI: 10.2169/internalmedicine.56.8343

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 28-year-old woman was referred to our hospital with treatment-resistant dermatomyositis (DM). She had been receiving moderate-dose prednisolone for 6 months; however, her myalgia, weakness, and cutaneous rash persisted. She had a rash on her face, chest, shoulders, elbows, knees, and her periungual areas, as well as a heliotrope rash and Gottron's sign. There were deep ulcers over the bilateral third metacarpophalangeal joints (Picture). Chest computed tomography (CT) revealed peripheral infiltration in both lungs. Methylprednisolone pulse therapy was started, followed by oral prednisolone and cyclosporine. Because the ulcers did not improve, prednisolone and cyclosporine were switched to dexamethasone and azathioprine, respectively. The local treatment of the skin lesions was also continued. The ulcers healed after 6 months. Repeat chest CT showed the improvement of the lung infiltration. The patient was positive for anti-melanoma differentiation-associated gene 5 (MDA5) antibodies, at a titer of 256 (normal <32). Rapidly-progressive interstitial lung disease, which is a well-known complication of anti-MDA5 antibody-positive DM, affects 20-70% of the patients with this antibody (1-3). In the present case, the cutaneous ulcers seen with Gottron's sign were also associated with this antibody, which is found in 12-80% of patients (1-5).
Picture.

The authors state that they have no Conflict of Interest (COI).
  5 in total

1.  Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

Authors:  Yasuhito Hamaguchi; Masataka Kuwana; Kana Hoshino; Minoru Hasegawa; Kenzo Kaji; Takashi Matsushita; Kazuhiro Komura; Motonobu Nakamura; Masanari Kodera; Norihiro Suga; Akira Higashi; Koji Ogusu; Kiyohiro Tsutsui; Akira Furusaki; Hiroshi Tanabe; Shunsuke Sasaoka; Yoshinao Muro; Mika Yoshikawa; Naoko Ishiguro; Masahiro Ayano; Eiji Muroi; Keita Fujikawa; Yukihiro Umeda; Masaaki Kawase; Eriko Mabuchi; Yoshihide Asano; Kinuyo Sodemoto; Mariko Seishima; Hidehiro Yamada; Shinichi Sato; Kazuhiko Takehara; Manabu Fujimoto
Journal:  Arch Dermatol       Date:  2011-04

2.  Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease.

Authors:  Neera S Narang; Livia Casciola-Rosen; Shufeng Li; Lorinda Chung; David F Fiorentino
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

3.  Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.

Authors:  Hua Cao; Qunli Xia; Meng Pan; Xiaoqing Zhao; Xia Li; Ruofei Shi; Min Zhou; Xiaoyi Ding; Masataka Kuwana; Jie Zheng
Journal:  J Rheumatol       Date:  2016-06-15       Impact factor: 4.666

Review 4.  Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.

Authors:  Zhiyong Chen; Mengshu Cao; Maria Nieves Plana; Jun Liang; Hourong Cai; Masataka Kuwana; Lingyun Sun
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

5.  The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.

Authors:  David Fiorentino; Lorinda Chung; Jeff Zwerner; Antony Rosen; Livia Casciola-Rosen
Journal:  J Am Acad Dermatol       Date:  2011-04-29       Impact factor: 11.527

  5 in total
  2 in total

Review 1.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.

Authors:  Rochelle L Castillo; Alisa N Femia
Journal:  Ann Transl Med       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.